Annexon, Inc. (ANNX) vs Verastem, Inc. (VSTM)

Annexon, Inc. and Verastem, Inc. are both Biotechnology companies. Annexon, Inc. and Verastem, Inc. are of similar size ($720.4M and $694.6M). Annexon, Inc. has the higher net margin (0.00% vs −231.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Annexon, Inc. leads on 8 and Verastem, Inc. on 5.

Valuation

Metric ANNX VSTM Biotechnology median
P/E n/m n/m 7.88
P/S n/m 8.89 11.47
P/B 3.93 15.56 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 8.29 10.73
Earnings yield (31.87%) (31.66%) (28.84%)
Free cash flow yield (26.41%) (20.85%) (23.03%)

Profitability

Metric ANNX VSTM Biotechnology median
Gross margin 0.00% 86.35% 65.16%
Operating margin 0.00% (182.57%) 0.00%
Net margin 0.00% (231.59%) 0.00%
Free cash flow margin 0.00% (185.31%) 0.00%
Return on equity (105.26%) (471.16%) (57.72%)
Return on assets (79.38%) (100.65%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANNX VSTM Biotechnology median
Revenue growth (TTM) — 472.89% 5.64%
EPS growth (last fiscal year) (32.67%) 17.49% —
Revenue growth, 5-year CAGR — 12.11% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANNX VSTM Biotechnology median
Debt to equity 0.00 1.48 0.00
Current ratio 5.53 2.25 4.73
Net debt to EBITDA 1.11 0.76 0.96

Dividend

Metric ANNX VSTM Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ANNX VSTM Biotechnology median
Market cap 720.40m 694.62m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack